ClinConnect ClinConnect Logo
Search / Trial NCT05215522

Tele BCI-FES for Upper -Limb Stoke Rehabilitation

Launched by UNIVERSITY OF SHEFFIELD · Jan 28, 2022

Trial Information

Current as of August 02, 2025

Completed

Keywords

Brain Computer Interface Functional Electrical Stimulation Tele Rehabilitation Stroke Rehabilitation

ClinConnect Summary

Movements of different parts of the body, including the arm, start when the brain produces specific electrical signals. Sometimes after a stroke, even though the person intends to move the arm, the arm will not move or will only move partly. The brain continues to produce electrical signals after stroke, but when the signals are weak the arm does not move. Brain-computer interface (BCI), is a method of utilising the brain signals to produce useful outputs via computers. One type of BCI is BCI Functional Electrical Stimulus (BCI-FES) which is a device that can detect these brain signals prod...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1) Age 18 and above.
  • (2) Experienced an ischaemic or haemorrhagic stroke more than 6 months ago.
  • (3) Arm weakness interfering with activities of daily living.
  • (4) Fugl-Meyer score of upper limb\<45.
  • (5) Caregiver is willing to assist with trial by helping to deliver intervention.
  • (6) Cognitive and language abilities to understand and participate in the study protocol.
  • (7) Can maintain sitting with or without support for 1 hour continuously.
  • (8) Able to give consent and understand instructions.
  • Exclusion criteria:
  • 1. Cognitive impairment that would interfere with their ability to comply with the experimental protocol or provide informed consent;
  • 2. Dermatological, rheumatologic or orthopaedic illnesses of the affected arm interfering with movement of the elbow;
  • 3. Pre-existing severe systemic disorders like cardiovascular disease; active cancer or renal disease; end stage pulmonary or cardiovascular disease; psychiatric illness including severe alcohol or drug abuse
  • 4. Inability to perform the baseline assessments;
  • 5. Severe tactile hypersensitivity;
  • 6. Participation in other, upper limb rehabilitation studies
  • 7. Within 12 weeks of receiving Botulinum toxin injections;
  • 8. History of epilepsy
  • 9. Pace maker or any other implanted devices
  • 10. Pregnancy
  • 11. Severe dystonia/spasm

About University Of Sheffield

The University of Sheffield is a prestigious research institution located in the United Kingdom, renowned for its commitment to advancing medical science and improving patient outcomes through innovative clinical research. With a multidisciplinary approach, the university fosters collaboration among leading experts in various fields, facilitating cutting-edge studies that address critical health challenges. The University of Sheffield's clinical trials are designed to adhere to rigorous ethical standards and regulatory requirements, ensuring the reliability and integrity of their findings while contributing to the global body of medical knowledge. Through its dedication to excellence in research and education, the university aims to translate scientific discoveries into real-world applications that enhance health and well-being.

Locations

Sheffield, South Yorkshire, United Kingdom

Patients applied

0 patients applied

Trial Officials

Mahnaz Arvaneh, PhD

Principal Investigator

University of Sheffield

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials